Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://ncbi.nlm.nih.gov/pubmed/29979712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0199642
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi